| Literature DB >> 25259805 |
Zining Cui1, Jun Ito2, Hirofumi Dohi3, Yoshimiki Amemiya2, Yoshihiro Nishida3.
Abstract
A new series of salicyl glycoconjugates containingEntities:
Mesh:
Substances:
Year: 2014 PMID: 25259805 PMCID: PMC4178153 DOI: 10.1371/journal.pone.0108338
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1General synthetic procedure for salicylic glycoconjugates.
In vitro fungicidal activity against five fungus species at 50 µg/mL.
| Compd. | Inhibitory rate (%) | ||||
|
|
|
|
|
| |
|
| 97.3±2.0 | 73.0±2.2 | 73.1±2.1 | 86.5±2.3 | 56.2±2.2 |
|
| 95.4±1.3 | 95.5±2.3 | 77.7±2.3 | 79.2±1.7 | 61.7±1.8 |
|
| 11.3±1.0 | 12.2±1.1 | 28.1±2.0 | 27.9±1.6 | 13.2±1.1 |
|
| 28.6±1.2 | 28.0±1.5 | 10.3±1.5 | 28.9±2.0 | 28.4±1.3 |
|
| 12.9±1.2 | 9.3±0.4 | 6.5±0.6 | 18.1±2.0 | 12.9±1.7 |
|
| 8.1±0.4 | 11.6±1.0 | 11.5±2.1 | 23.0±2.0 | 2.0±0.4 |
|
| 15.2±0.9 | 7.4±0.2 | 10.4±1.7 | 26.1±1.0 | 21.6±1.0 |
|
| 19.7±1.1 | 9.4±0.7 | 25.9±2.6 | 12.9±1.1 | 26.7±1.6 |
|
| 2.2±0.3 | 3.2±0.1 | 1.3±0.8 | 16.3±2.4 | 23.8±1.2 |
|
| 17.6±1.3 | 13.3±1.2 | 15.2±1.4 | 19.5±1.3 | 28.4±2.3 |
|
| 24.4±1.2 | 35.3±1.7 | 28.5±2.0 | 15.4±1.0 | 21.4±1.3 |
|
| 15.7±1.8 | 24.7±1.4 | 37.5±2.3 | 47.6±1.5 | 31.6±1.8 |
|
| 25.5±1.7 | 33.3±1.6 | 17.5±1.1 | 39.4±2.0 | 38.6±1.2 |
|
| 13.3±1.9 | 25.3±1.3 | 36.5±1.6 | 38.4±1.3 | 29.0±1.4 |
|
| 25.5±1.0 | 21.5±1.1 | 19.6±1.7 | 19.8±1.0 | 41.5±1.5 |
|
| 6.0±1.0 | 12.6±1.1 | 27.6±1.6 | 37.6±2.5 | 24.5±1.2 |
|
| 11.3±0.6 | 8.2±0.8 | 12.4±1.6 | 21.5±1.5 | 15.7±1.1 |
| DMSO | 1.0±0.3 | 1.9±0.7 | 1.0±0.1 | 1.4±0.5 | 1.0±0.2 |
| Fungicides | 91.0±1.3 a | 98.2±1.2 b | 97.5±2.1 c | 91.0±2.1 d | 91.2±2.5 e |
Control fungicides: a, thiophanate-methyl; b, benomyl; c, chlorothalonil; d, validamycin; e, dimethomorph.
Figure 2In vitro fungicidal activity against Fusarium oxysporum.
A: blank control, B: 5d, C: DMSO, D: 2b, E: benomyl, F: 2a.
Figure 3In vitro fungicidal activity against Colletotrichum orbiculare.
A: blank control, B: 5d, C: DMSO, D: 2b, E: thiophanate-methyl, F: 2a.
In vivo antifungal activity against five fungus species at 500 µg/mL.
| Compd. | Inhibitory rate (%) | ||||
|
|
|
|
|
| |
|
| 51.8±2.0 | 55.2±2.2 | 48.1±3.1 | 51.7±2.2 | 33.2±1.3 |
|
| 61.7±1.1 | 64.5±2.4 | 43.5±2.2 | 51.8±3.1 | 26.8±1.1 |
|
| 45.6±2.6 | 43.6±2.3 | 41.9±1.1 | 49.7±2.3 | 12.9±1.2 |
|
| 41.6±1.2 | 28.1±1.0 | 39.4±1.7 | 21.5±1.5 | 11.3±0.6 |
|
| 51.6±1.7 | 59.7±2.1 | 49.3±2.3 | 17.4±1.9 | 3.2±0.9 |
|
| 47.5±1.8 | 34.5±1.6 | 34.7±1.3 | 43.8±1.6 | 6.6±0.3 |
|
| 50.3±1.3 | 54.5±1.2 | 50.8±1.7 | 26.0±1.3 | 40.4±2.2 |
|
| 53.3±1.8 | 61.8±2.0 | 53.7±2.5 | 45.0±2.0 | 11.3±1.7 |
|
| 34.6±1.6 | 55.6±0.8 | 54.5±1.3 | 34.5±1.4 | 24.2±1.0 |
|
| 68.6±1.3 | 71.0±2.3 | 73.9±2.6 | 31.2±1.4 | 12.9±1.2 |
|
| 41.3±0.5 | 53.8±1.5 | 52.3±1.1 | 45.5±2.1 | 76.0±2.2 |
|
| 48.3±1.3 | 33.6±1.5 | 54.5±1.5 | 36.8±1.9 | 68.6±1.5 |
|
| 54.8±1.9 | 62.6±1.6 | 34.5±0.7 | 28.6±1.5 | 83.5±1.3 |
|
| 12.6±0.3 | 34.5±1.0 | 37.8±1.3 | 36.6±1.9 | 78.5±1.6 |
|
| 54.3±2.5 | 54.6±0.9 | 23.3±1.2 | 33.2±1.8 | 77.5±2.0 |
|
| 59.6±1.8 | 74.9±1.3 | 14.7±0.8 | 14.5±1.0 | 25.6±1.1 |
|
| 54.8±1.5 | 40.3±1.2 | 42.8±1.3 | 33.9±1.5 | 34.7±1.0 |
| DMSO | 2.2±0.6 | 2.9±0.2 | 2.4±0.4 | 2.2±0.8 | 3.1±0.6 |
| Fungicides | 76.8±2.3 a | 74.5±2.3 b | 94.6±1.7 c | 81.0±2.7 d | 91.2±2.4 e |
Control fungicides: a, 70% thiophanate-methyl WP; b, 70% benomyl WP; c, 50% chlorothalonil WP; d, 3% validamycin AS; e, 50% dimethomorph WP.
Figure 4In vivo antifungal activity against Colletotrichum orbiculare.
Figure 5In vivo antifungal activity against Sphaerotheca fuliginea.
Figure 6Effect of designed compounds on inducing the expression of pathogenesis-related genes in Cucumis sativus.